Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
miRNAs as prognostic predictors in acute myeloid leukemia.
Transl Cancer Res. 2023 Jul 31;12(7):1656-1659. doi: 10.21037/tcr-23-716. Epub 2023 Jun 25.
Transl Cancer Res. 2023.
PMID: 37588737
Free PMC article.
No abstract available.
Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms.
Lima K, Carlos JAEG, Alves-Paiva RM, Vicari HP, Souza Santos FP, Hamerschlak N, Costa-Lotufo LV, Traina F, Machado-Neto JA.
Lima K, et al. Among authors: carlos jaeg.
Sci Rep. 2019 Jul 9;9(1):9895. doi: 10.1038/s41598-019-46163-2.
Sci Rep. 2019.
PMID: 31289316
Free PMC article.
Item in Clipboard
Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia.
Carlos JAEG, Lima K, Coelho-Silva JL, de Melo Alves-Paiva R, Moreno NC, Vicari HP, de Souza Santos FP, Hamerschlak N, Costa-Lotufo LV, Traina F, Machado-Neto JA.
Carlos JAEG, et al.
Cell Oncol (Dordr). 2020 Dec;43(6):1191-1201. doi: 10.1007/s13402-020-00551-3. Epub 2020 Aug 28.
Cell Oncol (Dordr). 2020.
PMID: 32857324
Item in Clipboard
AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis.
Carlos JAEG, Lima K, Costa-Lotufo LV, Leitão A, Machado-Neto JA.
Carlos JAEG, et al.
Invest New Drugs. 2021 Aug;39(4):1139-1149. doi: 10.1007/s10637-021-01066-w. Epub 2021 Jan 21.
Invest New Drugs. 2021.
PMID: 33475938
Item in Clipboard
Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax.
Lima K, Vicari HP, Carlos JAEG, da Silva JCL, Figueiredo-Pontes LL, Rego EM, Machado-Neto JA.
Lima K, et al. Among authors: carlos jaeg.
Hematol Transfus Cell Ther. 2022 Jan-Mar;44(1):124-127. doi: 10.1016/j.htct.2021.01.004. Epub 2021 Mar 13.
Hematol Transfus Cell Ther. 2022.
PMID: 33753045
Free PMC article.
No abstract available.
Item in Clipboard
AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy.
de Almeida LC, Carlos JAEG, Rezende-Teixeira P, Machado-Neto JA, Costa-Lotufo LV.
de Almeida LC, et al. Among authors: carlos jaeg.
Life Sci. 2022 Nov 1;308:120911. doi: 10.1016/j.lfs.2022.120911. Epub 2022 Aug 27.
Life Sci. 2022.
PMID: 36030982
Free article.
Item in Clipboard
Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells.
Parducci NS, Garnique ADMB, Lima K, Carlos JAEG, Fonseca NP, de Miranda LBL, de Almeida BO, Rego EM, Traina F, Machado-Neto JA.
Parducci NS, et al. Among authors: carlos jaeg.
Blood Cells Mol Dis. 2024 Jan;104:102799. doi: 10.1016/j.bcmd.2023.102799. Epub 2023 Oct 9.
Blood Cells Mol Dis. 2024.
PMID: 37839173
Item in Clipboard
HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents.
Waitman KB, de Almeida LC, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, de Souza VAM, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Costa-Lotufo LV, Machado-Neto JA, Tavares MT, Parise-Filho R.
Waitman KB, et al. Among authors: carlos jaeg.
Eur J Med Chem. 2024 Jan 5;263:115935. doi: 10.1016/j.ejmech.2023.115935. Epub 2023 Nov 10.
Eur J Med Chem. 2024.
PMID: 37989057
Item in Clipboard
Cite
Cite